Raffa, Robert B. and Pergolizzi, Joseph V. and Taylor, Robert (2018) The First Approved “Deuterated” Drug: A Short Review of the Concept. Pharmacology & Pharmacy, 09 (10). pp. 440-446. ISSN 2157-9423
PP_2018102517133837.pdf - Published Version
Download (571kB)
Abstract
The first “deuterated” drug has recently been approved by the U.S. FDA (Food & Drug Administration). A “deuterated” drug is a drug in which the hydrogen atom in one or more of the carbon-hydrogen bonds in its chemical structure is replaced by deuterium (“heavy hydrogen”, a hydrogen isotope that has a neutron, i.e., one neutron instead of the usual no neutrons). A carbon-deuterium (C-D) bond is more stable in the body than a carbon-hydrogen (C-H) bond. If the deuterium is strategically located in a drug’s chemical structure, the extra stability of the bond will be more resistant to metabolic breakdown, and the duration of drug action will be prolonged. We review the general concept of deuterated drugs, historical examples of the classes of application, and the new approval.
Item Type: | Article |
---|---|
Subjects: | AP Academic Press > Chemical Science |
Depositing User: | Unnamed user with email support@apacademicpress.com |
Date Deposited: | 22 Feb 2023 07:52 |
Last Modified: | 24 Jul 2024 09:18 |
URI: | http://info.openarchivespress.com/id/eprint/526 |